Ravulizumab: Solution concentrate for I.V. infusion 300 mg in 30 mL; Ultomiris® Page last updated: 13 November 2020 Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 2023KB) Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 553KB)